spondylitis

Correspondence on “Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial” by Molto et al
Uta Kiltz, Juergen Braun

Annals of the Rheumatic Diseases Dec 2023, 82 (12) e229; DOI: 10.1136/annrheumdis-2021-221423
Correspondence on ‘Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial’
Weijie Wang, Yung-Heng Lee, James Cheng Chung Wei

Annals of the Rheumatic Diseases Nov 2023, 82 (11) e222; DOI: 10.1136/annrheumdis-2021-220938
Correspondence on ‘Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence’
Zheng-Liang Zhang, Wei Huang, Guo-Hua Lv, Jing Li, Ming-Xiang Zou, Zhi-Hui Dai

Annals of the Rheumatic Diseases Dec 2022, 81 (12) e252; DOI: 10.1136/annrheumdis-2020-218921
Response to ‘Correspondence on “Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence” by Zhang et al
Bon San Koo, Ji Seon Oh, Seo Young park, Ji Hui Shin, Ga Young Ahn, Seunghun Lee, Kyung Bin Joo, Tae-Hwan Kim

Annals of the Rheumatic Diseases Dec 2022, 81 (12) e253; DOI: 10.1136/annrheumdis-2020-218944
Response to: ‘Correspondence to ‘Normal human enthesis harbours conventional CD4+ and CD8+ T cells with regulatory features and inducible IL-17A and TNF expression’’ by Wang and Ma
Abdulla Watad, Charlie Bridgewood, Dennis G McGonagle

Annals of the Rheumatic Diseases Dec 2022, 81 (12) e255; DOI: 10.1136/annrheumdis-2020-219047
Case of postpartum axial spondyloarthritis
Kazunori Furuhashi, Nanase Honda, Yuji Miyoshi, Naoto Yokogawa

Annals of the Rheumatic Diseases Sep 2022, 81 (9) e171; DOI: 10.1136/annrheumdis-2020-218587
No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’?
Juergen Braun, Robert BM Landewé

Annals of the Rheumatic Diseases Apr 2022, 81 (4) 466-468; DOI: 10.1136/annrheumdis-2021-221422
Correspondence on ‘MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group’
Zaid Jibri, Ummugulsum Gazel, Dilek Solmaz, Gizem Ayan, Jacob Karsh, Sibel Zehra Aydin, Marcos Sampaio

Annals of the Rheumatic Diseases May 2023, 82 (5) e121; DOI: 10.1136/annrheumdis-2021-220008
Response to: ‘Correspondence on ‘MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group’’ by Jibri et al
Walter P Maksymowych, Robert GW Lambert, Mikkel Østergaard, Xenofon Baraliakos

Annals of the Rheumatic Diseases May 2023, 82 (5) e122; DOI: 10.1136/annrheumdis-2021-220078
Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry’
James Todd Rosenbaum, Michael H Weisman, Cassie Shafer, Elin Aslanyan, Richard A Howard, Kimberly Ogle, Hedley Hamilton, John D Reveille, Kevin L Winthrop, Dongseok Choi

Annals of the Rheumatic Diseases Jun 2023, 82 (6) e138; DOI: 10.1136/annrheumdis-2021-220588

Main menu

spondylitis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

spondylitis

Pages